TCT-701 Two Year Outcomes Following Unprotected Left Main Stenting with First- vs. New-Generation Drug-Eluting Stents: The FINE Registry

TCT-701 Two Year Outcomes Following Unprotected Left Main Stenting with First- vs. New-Generation Drug-Eluting Stents: The FINE Registry

The study endpoint was major adverse cardiac events (MACE), defined as all-cause mortality, target vessel revascularization (TVR) and myocardial infarction (MI) at 2-years clinical follow-up.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2012-10, Vol.60 (17), p.B204-B204
Hauptverfasser: Buchanan, Gill, Chieffo, Alaide, Bernelli, Chiara, Montorfano, Matteo, Carlino, Mauro, Latib, Azeem, Figini, Filippo, Franzoni, Irene, Ferrarello, Santo, Ielasi, Alfonso, Sacco, Francesco, Slavich, Massimo, Durante, Alessandro, Castelli, Alfredo, Colombo, Antonio
Format: Artikel
Sprache:eng
Schlagworte:
Cardiology
Cardiovascular
Drug therapy
Heart attacks
Internal Medicine
Mortality
Stents
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The study endpoint was major adverse cardiac events (MACE), defined as all-cause mortality, target vessel revascularization (TVR) and myocardial infarction (MI) at 2-years clinical follow-up.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2012.08.740